Paget's disease of the breast differential diagnosis: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 17: | Line 17: | ||
*[[Bowen’s disease]] | *[[Bowen’s disease]] | ||
*[[Basal cell carcinoma|Superficial basal cell carcinoma]] | *[[Basal cell carcinoma|Superficial basal cell carcinoma]] | ||
*[[Intraductal papilloma|Benign intraductal papilloma]] | *[[Intraductal papilloma|Benign intraductal papilloma]] | ||
*Pagetoid dyskeratosis | *Pagetoid dyskeratosis | ||
Line 52: | Line 51: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | Scalp, face, trunk, postauricular, diaper area and axilla | | align="center" style="background:#F5F5F5;" | Scalp, face, trunk, postauricular, diaper area and axilla | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
Line 72: | Line 71: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! rowspan=" | ! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]] | ||
| align="center" style="background:#F5F5F5;" |Benign | | align="center" style="background:#F5F5F5;" |Benign | ||
Line 81: | Line 80: | ||
*[[Erythema]], [[Exudate|exudates]], [[papules]],[[vesicles]], scales and crusts | *[[Erythema]], [[Exudate|exudates]], [[papules]],[[vesicles]], scales and crusts | ||
* Infiltrated [[erythema]], [[prurigo]], scales and crusts | * Infiltrated [[erythema]], [[prurigo]], scales and crusts | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 121: | Line 120: | ||
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | * Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | ||
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]] | | align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 147: | Line 146: | ||
* Dysregulation of the [[immune system]] | * Dysregulation of the [[immune system]] | ||
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | | align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 174: | Line 173: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Melanoma|Malignant melanoma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Melanoma|Malignant melanoma]] | ||
| align="center" style="background:#F5F5F5;" |Malignant | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Neural crest cell]] derivative | |||
* Development begins with disruption of [[nevus]] growth control | |||
* Progression involves [[MAPK/ERK pathway]] | |||
* [[RAS|N-RAS]] or [[BRAF]] [[oncogene]]<nowiki/>also involved | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Macule | |||
* Plaque with irregular border | |||
* Variable size | |||
* A lesion with [[ABCD]] | |||
** Asymmetry | |||
** Border irregularity | |||
** Color variation | |||
** Diameterchanges | |||
* [[Bleeding]] from the lesion | |||
| align="center" style="background:#F5F5F5;" |– | |||
[[Bleeding]] from the lesion may be present | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* All [[UV radiation]]<nowiki/>or sun exposed areas can be effected independently | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 186: | Line 204: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | * [[Ultraviolet|UV radiations]] | ||
| | * [[Genetic predisposition]] | ||
* [[Old age]] | |||
* Male gender | |||
* Family or personal history of [[melanoma]] | |||
* Multiple benign or atypical [[Nevus|nevi]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bowen’s disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bowen’s disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Benign can turn malignant | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 200: | Line 222: | ||
* scaly | * scaly | ||
* variable size | * variable size | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 210: | Line 232: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Presence of dotted and/or glomerular vessels | |||
* White to yellowish surface scales | |||
* Red-yellowish background | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 219: | Line 244: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Slow growth over the years | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Basal cell carcinoma|Superficial basal cell carcinoma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Basal cell carcinoma|Superficial basal cell carcinoma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Malignant | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Erythematous | * Erythematous | ||
* Superficial scaly patch | * Superficial scaly patch | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 246: | Line 272: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Higher incidence in men | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] |
Revision as of 17:12, 21 February 2019
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast differential diagnosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis |
Paget's disease of the breast differential diagnosis in the news |
Blogs on Paget's disease of the breast differential diagnosis |
Directions to Hospitals Treating Paget's disease of the breast |
Risk calculators and risk factors for Paget's disease of the breast differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Category | Diseases | Benign or Malignant | Etiology | Clinical manifestations | Para-clinical findings | Gold Standard | Associated factors | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Histopathology | ||||||||||||||
Rash | Nipple Discharge | Erythema | Involved areas | Mastalgia | Breast Exam | Other | Serum IgE | ||||||||
Eczema | Scalp, face, trunk, postauricular, diaper area and axilla | – | + | – | + |
|
Nl |
|
Risk factors include
Generalized seborrheic erythroderma in immunodeficient patients |
||||||
Skin disorders | Atopic dermatitis | Benign |
|
– | – | + |
|
– |
|
↑ |
|
| |||
Allergic contact dermatitis[3] | Benign |
|
Erythematous well-demarcated papules | – | – | + | Surrounding the area in contact with the offending agent | + |
|
Nl |
|
| |||
Psoriasis | Benign |
|
Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | – | + | + |
|
+ |
|
Nl |
|
Risk factors include
| |||
Malignant melanoma | Malignant |
|
|
–
Bleeding from the lesion may be present |
|
| |||||||||
Bowen’s disease | Benign can turn malignant |
|
– |
|
|
|
| ||||||||
Superficial basal cell carcinoma | Malignant |
|
– |
|
|
|
| ||||||||
Benign intraductal papilloma | |||||||||||||||
Pagetoid dyskeratosis | |||||||||||||||
Lactiferous duct ectasia | Benign | * Common among perimenopausalwomen
|
* Distention of subareolar ducts | Ultrasound:
|
|||||||||||
Nipple duct adenoma | |||||||||||||||
Benign Toker cell hyperplasia | |||||||||||||||
Breast abscess | Benign | + |
|
|
|||||||||||
Mondors disease | |||||||||||||||
Mastitis |
|
+ | ± |
|
|
||||||||||
Inflammatory Breast Cancer |
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.